Equillium, Inc. - Common Stock, par value $0.0001 per share (EQ)
CUSIP: 29446K106
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 66,704,586
- Total 13F shares
- 8,717,452
- Share change
- -171,870
- Total reported value
- $7,247,939
- Price per share
- $0.83
- Number of holders
- 24
- Value change
- -$126,669
- Number of buys
- 8
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 29446K106?
CUSIP 29446K106 identifies EQ - Equillium, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29446K106:
Top shareholders of EQ - Equillium, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Decheng Capital LLC |
13F
|
Company |
6.7%
|
4,447,308
|
$3,082,874 | — | 30 Jun 2024 | |
| TAKEDA PHARMACEUTICAL CO LTD |
13F
|
Company |
2.7%
|
1,824,977
|
$1,259,234 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
841,948
|
$583,639 | — | 30 Jun 2024 | |
| Cota Capital Management, LLC |
13F
|
Company |
0.84%
|
562,278
|
$389,771 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.45%
|
300,400
|
$208,237 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
216,204
|
$149,898 | — | 30 Jun 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.21%
|
140,775
|
$97,585 | — | 30 Jun 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.16%
|
108,691
|
$73,000 | — | 30 Jun 2024 | |
| Callan Capital, LLC |
13F
|
Company |
0.15%
|
99,688
|
$69,104 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.09%
|
59,720
|
$41,398 | — | 30 Jun 2024 | |
| Joel Rothman |
3/4/5
|
Chief Development Officer |
—
mixed-class rows
|
233,150
mixed-class rows
|
$33,727 | — | 02 Jan 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.07%
|
43,504
|
$30,157 | — | 30 Jun 2024 | |
| Integrated Wealth Concepts LLC |
13F
|
Company |
0.06%
|
40,000
|
$27,728 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.06%
|
38,317
|
$26,562 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.05%
|
35,019
|
$24,275 | — | 30 Jun 2024 | |
| DCF Advisers, LLC |
13F
|
Company |
0.05%
|
32,962
|
$22,849 | — | 30 Jun 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.05%
|
30,506
|
$21,000 | — | 30 Jun 2024 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.04%
|
25,000
|
$17,000 | — | 30 Jun 2024 | |
| TRITONPOINT WEALTH, LLC |
13F
|
Company |
0.02%
|
13,500
|
$9,358 | — | 30 Jun 2024 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.02%
|
10,119
|
$7,014 | — | 30 Jun 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.01%
|
9,071
|
$6,000 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
6,287
|
$4,357 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,000
|
$693 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
158
|
$109 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
43
|
$30 | — | 30 Jun 2024 | |
| Ph.D. Yu Xu |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 22 May 2024 |
Institutional Holders of Equillium, Inc. - Common Stock, par value $0.0001 per share (EQ) as of Q3 2024
As of 30 Sep 2024,
Equillium, Inc. - Common Stock, par value $0.0001 per share (EQ) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,717,452 shares.
The largest 10 holders included
Decheng Capital LLC, TAKEDA PHARMACEUTICAL CO LTD, VANGUARD GROUP INC, Cota Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, ACADIAN ASSET MANAGEMENT LLC, Callan Capital, LLC, STATE STREET CORP, and BlackRock, Inc..
This page lists
25
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
24
Q3 2024 holders
24
Holder diff
0
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.